NYSE:RCOR - Renovacor Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $21.00
  • Forecasted Upside: 168.89 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$7.81
▲ +0.01 (0.13%)

This chart shows the closing price for RCOR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Renovacor Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RCOR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RCOR

Analyst Price Target is $21.00
▲ +168.89% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Renovacor in the last 3 months. The average price target is $21.00, with a high forecast of $22.00 and a low forecast of $20.00. The average price target represents a 168.89% upside from the last price of $7.81.

This chart shows the closing price for RCOR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 contributing investment analysts is to buy stock in Renovacor.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/23/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/22/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/20/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/19/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/18/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
10/14/2021LADENBURG THALM/SH SHInitiated CoverageBuy$22.00High
10/1/2021Chardan CapitalInitiated CoverageBuy$20.00Low
(Data available from 1/18/2017 forward)

News Sentiment Rating

1.59 (Strong Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/21/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/20/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
10/20/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/19/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/19/2021
  • 5 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/18/2022

Current Sentiment

  • 5 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.
Renovacor logo
Renovacor Inc. is an early?stage biotechnology company developing adeno-associated virus based gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants. Renovacor Inc., formerly known as Chardan Healthcare Acquisition 2 Corp., is based in NEW YORK.
Read More

Today's Range

Now: $7.81
Low: $7.75
High: $8.23

50 Day Range

MA: $8.40
Low: $7.63
High: $9.39

52 Week Range

Now: $7.81
Low: $6.85
High: $11.12

Volume

185,435 shs

Average Volume

40,950 shs

Market Capitalization

$134.77 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Renovacor?

The following Wall Street sell-side analysts have issued research reports on Renovacor in the last twelve months: Chardan Capital, and LADENBURG THALM/SH SH.
View the latest analyst ratings for RCOR.

What is the current price target for Renovacor?

2 Wall Street analysts have set twelve-month price targets for Renovacor in the last year. Their average twelve-month price target is $21.00, suggesting a possible upside of 168.9%. LADENBURG THALM/SH SH has the highest price target set, predicting RCOR will reach $22.00 in the next twelve months. Chardan Capital has the lowest price target set, forecasting a price of $20.00 for Renovacor in the next year.
View the latest price targets for RCOR.

What is the current consensus analyst rating for Renovacor?

Renovacor currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe RCOR will outperform the market and that investors should add to their positions of Renovacor.
View the latest ratings for RCOR.

How do I contact Renovacor's investor relations team?

Renovacor's physical mailing address is 17 STATE STREET 21 FLOOR, NEW YORK NY, 10004. The company's listed phone number is 610-424-2650 and its investor relations email address is [email protected] The official website for Renovacor is renovacor.com.